Tata 1mg, India's largest digital health platform, is establishing its physical presence in Jaipur by opening six integrated pharmacy and diagnostics stores in various parts of the Pink City this month. The company owned and operated stores, with average size of 500 sq. ft., is
The partnership will combine West’s medical expertise with IIT’s unique incubation model to advance research in medical technology Bengaluru, Karnataka; West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug and healthcare products, recently announced its partnership with TECHIN – a
The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. Hyderabad-based Bharat Biotech
Zydus Cadila's Covid-19 vaccine may cost around Rs 300 per dose, people in the know told ET. As government inches closer to deciding the price of vaccine which is likely to be introduced in the vaccination drive this month, people who are part of discussions said that "the
WHO chief scientist Soumya Swaminathan has said, citing sero-survey results and huge learning loss over past 18 months that Tamil Nadu should consider reopening schools for all classes,. On Sunday in an event, Soumya said one of the main findings of ICMR’s fourth sero prevalence study conducted in June
According to an official statement on Friday, India has granted homegrown drugmaker Biological E permission to begin midtage studies of its COVID-19 vaccine in children and adolescents. The Drugs Controller General of India (DCGI) gave the approval to the Hyderabad-based pharmaceutical company on Sept. 1, the statement said. The
Arunachal Pradesh currently has 4,266 active cases, while 41,385 people have recovered from the disease thus far, including 360 in the last 24 hours. Zydus Cadila gets USFDA nod for arthritis drug Drug firm Zydus Cadila on Monday said it has received final approval from the US
Union health minister Mansukh Mandaviya on Thursday said the government has launched an inquiry into a report claiming that counterfeit versions of Covishield, India’s primary anti-COVID-19 vaccine, had been seized. “It has been claimed that duplicate versions of Covishield vaccine were sold in the country. The
Indian pharmaceutical major Zydus Cadila is likely to apply to the central drugs regulator seeking emergency use authorisation for its COVID-19 vaccine ZyCoV-D next week, official sources said on Friday. If approved, it will be the world’s first DNA vaccine against coronavirus and the fourth to
